Imricor Medical Systems (ASX:IMR) Equity-to-Asset : -1.05 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Imricor Medical Systems's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$-13.08 Mil. Imricor Medical Systems's Total Assets for the quarter that ended in Dec. 2023 was A$12.41 Mil. Therefore, Imricor Medical Systems's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was -1.05.

The historical rank and industry rank for Imricor Medical Systems's Equity-to-Asset or its related term are showing as below:

ASX:IMR' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.05 Med: 0.75 Max: 0.86
Current: -1.05

During the past 6 years, the highest Equity to Asset Ratio of Imricor Medical Systems was 0.86. The lowest was -1.05. And the median was 0.75.

ASX:IMR's Equity-to-Asset is ranked worse than
96.32% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs ASX:IMR: -1.05

Imricor Medical Systems Equity-to-Asset Historical Data

The historical data trend for Imricor Medical Systems's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems Equity-to-Asset Chart

Imricor Medical Systems Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.67

0.86

0.83

0.55

-1.05

Imricor Medical Systems Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial				0.83	0.75	0.55	-0.11	-1.05

Competitive Comparison of Imricor Medical Systems's Equity-to-Asset

For the Medical Devices subindustry, Imricor Medical Systems's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imricor Medical Systems's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imricor Medical Systems's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Imricor Medical Systems's Equity-to-Asset falls into.

Imricor Medical Systems Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Imricor Medical Systems's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-13.077	/	12.412
	=	-1.05

Imricor Medical Systems's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-13.077	/	12.412
	=	-1.05

Imricor Medical Systems (ASX:IMR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Imricor Medical Systems Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Imricor Medical Systems (ASX:IMR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Gateway Boulevard, Burnsville, MN, USA, 55337

Website

https://www.imricor.com

Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems (ASX:IMR) Headlines

No Headlines